Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder

[1]  S. Tada,et al.  Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder , 2022, Neurology: Neuroimmunology & Neuroinflammation.

[2]  T. Kanda,et al.  New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[3]  Jonathan R. McDaniel,et al.  Molecular Level Characterization of Circulating Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[4]  A. Kermode,et al.  NMOSD acute attack: Understanding, treatment and innovative treatment prospect , 2020, Journal of Neuroimmunology.

[5]  Y. Nakatsuji,et al.  Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation , 2020, Scientific Reports.

[6]  J. M. Behne,et al.  Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide , 2020, Frontiers in Neurology.

[7]  F. Paul,et al.  Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica , 2020, Nature Communications.

[8]  W. Brück,et al.  Molecular biomarkers in multiple sclerosis , 2019, Journal of Neuroinflammation.

[9]  Yumin Xia,et al.  Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies , 2019, Front. Immunol..

[10]  E. Flanagan.  Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases. , 2019, Continuum.

[11]  M. Lana-Peixoto,et al.  Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes , 2019, Biomedicines.

[12]  A. Jacob,et al.  Neuromyelitis optica spectrum disorders. , 2019, Clinical medicine.

[13]  Y. Nakatsuji,et al.  Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder , 2018, Journal of Neuroinflammation.

[14]  A. Maia,et al.  Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  Hongbo Hu,et al.  Self‐dsDNA in the pathogenesis of systemic lupus erythematosus , 2018, Clinical and experimental immunology.

[16]  B. Weinshenker,et al.  Neuromyelitis Spectrum Disorders , 2017, Mayo Clinic proceedings.

[17]  H. Mizusawa,et al.  Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases , 2016, Neural regeneration research.

[18]  W. Kozubski,et al.  International Journal of Molecular Sciences the Immunology of Neuromyelitis Optica—current Knowledge, Clinical Implications, Controversies and Future Perspectives , 2022 .

[19]  F. Paul,et al.  Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses , 2016, Annals of neurology.

[20]  J. P. Garrahan,et al.  Update on biomarkers in neuromyelitis optica , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[21]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[22]  R. Bergamaschi,et al.  Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures , 2011, Journal of the Neurological Sciences.

[23]  B. Hemmer,et al.  Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica , 2009, Annals of neurology.

[24]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[25]  S. Sakoda,et al.  Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. , 2009, Biochemical and biophysical research communications.

[26]  K. Fujihara,et al.  Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum , 2009, Neuroreport.

[27]  John J. Chen,et al.  Optic Neuritis In the Era of Biomarkers. , 2019, Survey of ophthalmology.

[28]  R. Gold,et al.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders , 2015, Neurotherapeutics.